During the past decade, Be Part Yoluntu Centre conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Be Part Yoluntu Centre" #1 sponsor was "Gilead Sciences" with 4 trials, followed by "Janssen Vaccines & Prevention B.V." with 2 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials sponsored, "Statens Serum Institut" with 2 trials sponsored and "Ferring Pharmaceuticals" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Be Part Yoluntu Centre" are "Acquired Immune Deficiency Syndrome (AIDS)" (3 trials), "HIV Infections" (3 trials), "Tuberculosis" (2 trials), "Chronic Idiopathic Constipation" (1 trials) and "HIV-1" (1 trials). Many other conditions were trialed in "Be Part Yoluntu Centre" in a lesser frequency.

Most popular intervention types in "Be Part Yoluntu Centre" are "Drug" (8 trials), "Biological" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "C-Tb" (2 trials), "F/TAF" (2 trials), "placebo" (2 trials) and "2 T.U. Tuberculin PPD RT 23 SSI" (1 trials). Other intervention names were less common.

The vast majority of trials in "Be Part Yoluntu Centre" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Be Part Yoluntu Centre". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Be Part Yoluntu Centre, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Be Part Yoluntu Centre, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".